Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 78 entries
View as:

A Clinical Study to Evaluate the Efficacy and Safety of YVOIRE Classic Plus Versus YVOIRE Classic in Nasolabial Fold Injection

Phase: N/A Priority: Normal
NCT ID: NCT02340091 Org: User:
Start: 02/28/14 End: 06/30/15 Due: 06/30/16

Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients

Phase: N/A Priority: Normal
NCT ID: NCT02415192 Org: User:
Start: 07/31/14 End: 11/30/16 Due: 11/30/17

To Assess the Anti-adhesive Effect and Safety of Protescal

Phase: N/A Priority: Normal
NCT ID: NCT01810900 Org: User:
Start: 09/30/12 End: 12/31/13 Due: 12/31/14

Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg

Phase: N/A Priority: Normal
NCT ID: NCT01918358 Org: User:
Start: 12/31/12 End: 01/31/13 Due: 01/31/14

A Clinical Trial to Evaluate the Safety and Efficacy of Retreatment With Intra-articular LBSA0103 Injections in the Patients With Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT02122601 Org: User:
Start: 04/30/14 End: 05/31/15 Due: 05/31/16

Treatment of Adults With Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT00294619 Org: User:
Start: 04/30/06 End: 03/31/08 Due: 03/31/09

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)

Phase: N/A Priority: Normal
NCT ID: NCT01662687 Org: User:
Start: 02/29/12 End: 11/30/12 Due: 11/30/13

Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks

Phase: N/A Priority: Normal
NCT ID: NCT02257645 Org: User:
Start: 03/31/15 End: 09/30/16 Due: 09/30/17

Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj.

Phase: N/A Priority: Normal
NCT ID: NCT02458768 Org: User:
Start: 07/31/13 End: - Due: -

Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C] LC15-0444

Phase: N/A Priority: Normal
NCT ID: NCT01603238 Org: User:
Start: 05/31/11 End: 07/31/11 Due: 07/31/12

Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)

Phase: N/A Priority: Normal
NCT ID: NCT01890629 Org: User:
Start: 05/31/13 End: 08/31/14 Due: 08/31/15

Clinical Study to Evaluate the Correction of Wrinkles and Folds and Safety of YVOIRE Classic Versus Restylane in Nasolabial Fold Intradermal Injection

Phase: N/A Priority: Normal
NCT ID: NCT03738020 Org: User:
Start: 01/31/09 End: 10/31/09 Due: 10/31/10

Pharmacokinetic Drug Interaction Between LC15-0444 and Pioglitazone After Oral Administration in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01001013 Org: User:
Start: 02/28/09 End: 12/31/09 Due: 12/31/10

A Clinical Study to Evaluate the Efficacy and Safety of YVOIRE Volume Plus Versus YVOIRE Volume in Nasolabial Fold Injection

Phase: N/A Priority: Normal
NCT ID: NCT02340078 Org: User:
Start: 11/30/13 End: 02/28/15 Due: 02/28/16

A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02746380 Org: User:
Start: 04/13/16 End: 02/23/18 Due: 02/23/19

Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volume s

Phase: N/A Priority: Normal
NCT ID: NCT02661737 Org: User:
Start: 05/31/15 End: 09/30/17 Due: 09/30/18

Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.d

Phase: N/A Priority: Normal
NCT ID: NCT01787396 Org: User:
Start: 04/30/13 End: 03/31/15 Due: 03/31/16

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01825850 Org: User:
Start: 06/30/13 End: 03/31/14 Due: 03/31/15

Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients

Phase: N/A Priority: Normal
NCT ID: NCT02070471 Org: User:
Start: 01/31/14 End: - Due: -

A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX)

Phase: N/A Priority: Normal
NCT ID: NCT02715908 Org: User:
Start: 04/30/16 End: 04/30/18 Due: 04/30/19

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered Alone

Phase: N/A Priority: Normal
NCT ID: NCT01595880 Org: User:
Start: 12/31/14 End: 01/31/15 Due: 01/31/16

Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189

Phase: N/A Priority: Normal
NCT ID: NCT01361646 Org: User:
Start: 06/30/11 End: 01/31/13 Due: 01/31/14

Pharmacokinetics and Safety Study of LBAL in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02206867 Org: User:
Start: 08/31/14 End: 02/28/15 Due: 02/28/16

Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT01242787 Org: User:
Start: 08/31/10 End: 09/30/12 Due: 09/30/13

Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02204163 Org: User:
Start: 06/30/14 End: 12/31/17 Due: 12/31/18